The next pandemic is already here. Covid can teach us how to fight it.
While covid-19 drew our attention to the threat of viruses, microbiologists have long worried that we have forgotten the threat of bacterial epidemics, and the growing danger that bacteria will become resistant to the drugs we rely upon.
“Antimicrobial resistance may not seem as urgent as a pandemic, but it is just as dangerous,” Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, said in November, calling it “one of the greatest health threats of our time.”
In 2014 the Review on Antimicrobial Resistance, a research group put together by the British government, estimated that antibiotic resistance kills 700,000 people around the world each year, a number that was horrifying then but seems small in comparison to the spiraling losses of covid-19. But the researchers also predicted that if nothing was done, the death rate by 2050 would reach 10 million per year— almost three times covid-19’s toll so far.
In other words: covid took us by surprise, but we already know another health crisis is coming, and now we know how to deal with it.
The response to covid-19 shows what can be accomplished when focus, determination, and vast amounts of money are all directed at one target. The pandemic reorganized the everyday practice of science, the pace of clinical trials, and the willingness of governments to provide funds for that work. With a similar effort applied to antibiotic resistance, we might reorganize trial design, create new surveillance networks to detect resistant pathogens as they emerge, and devise new ways to fund drug development.
Or, to state this more simply: we need to treat antimicrobial resistance as an emergency too. Because it already is. Read the full story.
—Maryn McKenna
This story is for subscribers only. Sign up if you haven't already! You can get full access to all of our award-winning journalism from just $50 a year.
No comments:
Post a Comment